Global Dermatology OTC Drug Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 30-Jun-2021
No. of pages: 117
Inquire Before Buying

Market Analysis and Insights: Global Dermatology OTC Drug Market

The global Dermatology OTC Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dermatology OTC Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dermatology OTC Drug market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dermatology OTC Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dermatology OTC Drug market.

Global Dermatology OTC Drug Scope and Market Size

Dermatology OTC Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dermatology OTC Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Antifungals Medication

- Skin Disinfection Medication

- Skin Irritation Medication

- Wounds and Herpes Simplex Medication

- Anti-Psoriasis Medication

- Other

Segment by Application

- Hospital

- Drug Store

- Other

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Bayer

- GSK

- Teva

- Johnson & Johnson

- Novartis

- Mylan

- Sun Pharmaceutical

- Aurobindo

- Galderma

- CR SANJIU

- Dr. Reddy's

- Lupin

- Bausch Health

- Cipla

- Livzon

- Almirall

- Lingrui

Global Dermatology OTC Drug Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dermatology OTC Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antifungals Medication
1.2.3 Skin Disinfection Medication
1.2.4 Skin Irritation Medication
1.2.5 Wounds and Herpes Simplex Medication
1.2.6 Anti-Psoriasis Medication
1.2.7 Other
1.3 Market by Application
1.3.1 Global Dermatology OTC Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Dermatology OTC Drug Market Perspective (2016-2027)
2.2 Dermatology OTC Drug Growth Trends by Regions
2.2.1 Dermatology OTC Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Dermatology OTC Drug Historic Market Share by Regions (2016-2021)
2.2.3 Dermatology OTC Drug Forecasted Market Size by Regions (2022-2027)
2.3 Dermatology OTC Drug Industry Dynamic
2.3.1 Dermatology OTC Drug Market Trends
2.3.2 Dermatology OTC Drug Market Drivers
2.3.3 Dermatology OTC Drug Market Challenges
2.3.4 Dermatology OTC Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dermatology OTC Drug Players by Revenue
3.1.1 Global Top Dermatology OTC Drug Players by Revenue (2016-2021)
3.1.2 Global Dermatology OTC Drug Revenue Market Share by Players (2016-2021)
3.2 Global Dermatology OTC Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Dermatology OTC Drug Revenue
3.4 Global Dermatology OTC Drug Market Concentration Ratio
3.4.1 Global Dermatology OTC Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dermatology OTC Drug Revenue in 2020
3.5 Dermatology OTC Drug Key Players Head office and Area Served
3.6 Key Players Dermatology OTC Drug Product Solution and Service
3.7 Date of Enter into Dermatology OTC Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dermatology OTC Drug Breakdown Data by Type
4.1 Global Dermatology OTC Drug Historic Market Size by Type (2016-2021)
4.2 Global Dermatology OTC Drug Forecasted Market Size by Type (2022-2027)
5 Dermatology OTC Drug Breakdown Data by Application
5.1 Global Dermatology OTC Drug Historic Market Size by Application (2016-2021)
5.2 Global Dermatology OTC Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Dermatology OTC Drug Market Size (2016-2027)
6.2 North America Dermatology OTC Drug Market Size by Type
6.2.1 North America Dermatology OTC Drug Market Size by Type (2016-2021)
6.2.2 North America Dermatology OTC Drug Market Size by Type (2022-2027)
6.2.3 North America Dermatology OTC Drug Market Size by Type (2016-2027)
6.3 North America Dermatology OTC Drug Market Size by Application
6.3.1 North America Dermatology OTC Drug Market Size by Application (2016-2021)
6.3.2 North America Dermatology OTC Drug Market Size by Application (2022-2027)
6.3.3 North America Dermatology OTC Drug Market Size by Application (2016-2027)
6.4 North America Dermatology OTC Drug Market Size by Country
6.4.1 North America Dermatology OTC Drug Market Size by Country (2016-2021)
6.4.2 North America Dermatology OTC Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Dermatology OTC Drug Market Size (2016-2027)
7.2 Europe Dermatology OTC Drug Market Size by Type
7.2.1 Europe Dermatology OTC Drug Market Size by Type (2016-2021)
7.2.2 Europe Dermatology OTC Drug Market Size by Type (2022-2027)
7.2.3 Europe Dermatology OTC Drug Market Size by Type (2016-2027)
7.3 Europe Dermatology OTC Drug Market Size by Application
7.3.1 Europe Dermatology OTC Drug Market Size by Application (2016-2021)
7.3.2 Europe Dermatology OTC Drug Market Size by Application (2022-2027)
7.3.3 Europe Dermatology OTC Drug Market Size by Application (2016-2027)
7.4 Europe Dermatology OTC Drug Market Size by Country
7.4.1 Europe Dermatology OTC Drug Market Size by Country (2016-2021)
7.4.2 Europe Dermatology OTC Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Dermatology OTC Drug Market Size (2016-2027)
8.2 Asia-Pacific Dermatology OTC Drug Market Size by Type
8.2.1 Asia-Pacific Dermatology OTC Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Dermatology OTC Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Dermatology OTC Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Dermatology OTC Drug Market Size by Application
8.3.1 Asia-Pacific Dermatology OTC Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Dermatology OTC Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Dermatology OTC Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Dermatology OTC Drug Market Size by Region
8.4.1 Asia-Pacific Dermatology OTC Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Dermatology OTC Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Dermatology OTC Drug Market Size (2016-2027)
9.2 Latin America Dermatology OTC Drug Market Size by Type
9.2.1 Latin America Dermatology OTC Drug Market Size by Type (2016-2021)
9.2.2 Latin America Dermatology OTC Drug Market Size by Type (2022-2027)
9.2.3 Latin America Dermatology OTC Drug Market Size by Type (2016-2027)
9.3 Latin America Dermatology OTC Drug Market Size by Application
9.3.1 Latin America Dermatology OTC Drug Market Size by Application (2016-2021)
9.3.2 Latin America Dermatology OTC Drug Market Size by Application (2022-2027)
9.3.3 Latin America Dermatology OTC Drug Market Size by Application (2016-2027)
9.4 Latin America Dermatology OTC Drug Market Size by Country
9.4.1 Latin America Dermatology OTC Drug Market Size by Country (2016-2021)
9.4.2 Latin America Dermatology OTC Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dermatology OTC Drug Market Size (2016-2027)
10.2 Middle East & Africa Dermatology OTC Drug Market Size by Type
10.2.1 Middle East & Africa Dermatology OTC Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Dermatology OTC Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Dermatology OTC Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Dermatology OTC Drug Market Size by Application
10.3.1 Middle East & Africa Dermatology OTC Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Dermatology OTC Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Dermatology OTC Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Dermatology OTC Drug Market Size by Country
10.4.1 Middle East & Africa Dermatology OTC Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Dermatology OTC Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Dermatology OTC Drug Introduction
11.1.4 Bayer Revenue in Dermatology OTC Drug Business (2016-2021)
11.1.5 Bayer Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Dermatology OTC Drug Introduction
11.2.4 GSK Revenue in Dermatology OTC Drug Business (2016-2021)
11.2.5 GSK Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Teva Business Overview
11.3.3 Teva Dermatology OTC Drug Introduction
11.3.4 Teva Revenue in Dermatology OTC Drug Business (2016-2021)
11.3.5 Teva Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Dermatology OTC Drug Introduction
11.4.4 Johnson & Johnson Revenue in Dermatology OTC Drug Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Dermatology OTC Drug Introduction
11.5.4 Novartis Revenue in Dermatology OTC Drug Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Mylan
11.6.1 Mylan Company Details
11.6.2 Mylan Business Overview
11.6.3 Mylan Dermatology OTC Drug Introduction
11.6.4 Mylan Revenue in Dermatology OTC Drug Business (2016-2021)
11.6.5 Mylan Recent Development
11.7 Sun Pharmaceutical
11.7.1 Sun Pharmaceutical Company Details
11.7.2 Sun Pharmaceutical Business Overview
11.7.3 Sun Pharmaceutical Dermatology OTC Drug Introduction
11.7.4 Sun Pharmaceutical Revenue in Dermatology OTC Drug Business (2016-2021)
11.7.5 Sun Pharmaceutical Recent Development
11.8 Aurobindo
11.8.1 Aurobindo Company Details
11.8.2 Aurobindo Business Overview
11.8.3 Aurobindo Dermatology OTC Drug Introduction
11.8.4 Aurobindo Revenue in Dermatology OTC Drug Business (2016-2021)
11.8.5 Aurobindo Recent Development
11.9 Galderma
11.9.1 Galderma Company Details
11.9.2 Galderma Business Overview
11.9.3 Galderma Dermatology OTC Drug Introduction
11.9.4 Galderma Revenue in Dermatology OTC Drug Business (2016-2021)
11.9.5 Galderma Recent Development
11.10 CR SANJIU
11.10.1 CR SANJIU Company Details
11.10.2 CR SANJIU Business Overview
11.10.3 CR SANJIU Dermatology OTC Drug Introduction
11.10.4 CR SANJIU Revenue in Dermatology OTC Drug Business (2016-2021)
11.10.5 CR SANJIU Recent Development
11.11 Dr. Reddy's
11.11.1 Dr. Reddy's Company Details
11.11.2 Dr. Reddy's Business Overview
11.11.3 Dr. Reddy's Dermatology OTC Drug Introduction
11.11.4 Dr. Reddy's Revenue in Dermatology OTC Drug Business (2016-2021)
11.11.5 Dr. Reddy's Recent Development
11.12 Lupin
11.12.1 Lupin Company Details
11.12.2 Lupin Business Overview
11.12.3 Lupin Dermatology OTC Drug Introduction
11.12.4 Lupin Revenue in Dermatology OTC Drug Business (2016-2021)
11.12.5 Lupin Recent Development
11.13 Bausch Health
11.13.1 Bausch Health Company Details
11.13.2 Bausch Health Business Overview
11.13.3 Bausch Health Dermatology OTC Drug Introduction
11.13.4 Bausch Health Revenue in Dermatology OTC Drug Business (2016-2021)
11.13.5 Bausch Health Recent Development
11.14 Cipla
11.14.1 Cipla Company Details
11.14.2 Cipla Business Overview
11.14.3 Cipla Dermatology OTC Drug Introduction
11.14.4 Cipla Revenue in Dermatology OTC Drug Business (2016-2021)
11.14.5 Cipla Recent Development
11.15 Livzon
11.15.1 Livzon Company Details
11.15.2 Livzon Business Overview
11.15.3 Livzon Dermatology OTC Drug Introduction
11.15.4 Livzon Revenue in Dermatology OTC Drug Business (2016-2021)
11.15.5 Livzon Recent Development
11.16 Almirall
11.16.1 Almirall Company Details
11.16.2 Almirall Business Overview
11.16.3 Almirall Dermatology OTC Drug Introduction
11.16.4 Almirall Revenue in Dermatology OTC Drug Business (2016-2021)
11.16.5 Almirall Recent Development
11.17 Lingrui
11.17.1 Lingrui Company Details
11.17.2 Lingrui Business Overview
11.17.3 Lingrui Dermatology OTC Drug Introduction
11.17.4 Lingrui Revenue in Dermatology OTC Drug Business (2016-2021)
11.17.5 Lingrui Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Dermatology OTC Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antifungals Medication
Table 3. Key Players of Skin Disinfection Medication
Table 4. Key Players of Skin Irritation Medication
Table 5. Key Players of Wounds and Herpes Simplex Medication
Table 6. Key Players of Anti-Psoriasis Medication
Table 7. Key Players of Other
Table 8. Global Dermatology OTC Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Dermatology OTC Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Dermatology OTC Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Dermatology OTC Drug Market Share by Regions (2016-2021)
Table 12. Global Dermatology OTC Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Dermatology OTC Drug Market Share by Regions (2022-2027)
Table 14. Dermatology OTC Drug Market Trends
Table 15. Dermatology OTC Drug Market Drivers
Table 16. Dermatology OTC Drug Market Challenges
Table 17. Dermatology OTC Drug Market Restraints
Table 18. Global Dermatology OTC Drug Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Dermatology OTC Drug Market Share by Players (2016-2021)
Table 20. Global Top Dermatology OTC Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatology OTC Drug as of 2020)
Table 21. Ranking of Global Top Dermatology OTC Drug Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Dermatology OTC Drug Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Dermatology OTC Drug Product Solution and Service
Table 25. Date of Enter into Dermatology OTC Drug Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Dermatology OTC Drug Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Dermatology OTC Drug Revenue Market Share by Type (2016-2021)
Table 29. Global Dermatology OTC Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Dermatology OTC Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Dermatology OTC Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Dermatology OTC Drug Revenue Market Share by Application (2016-2021)
Table 33. Global Dermatology OTC Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Dermatology OTC Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Dermatology OTC Drug Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Dermatology OTC Drug Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Dermatology OTC Drug Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Dermatology OTC Drug Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Dermatology OTC Drug Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Dermatology OTC Drug Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Dermatology OTC Drug Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Dermatology OTC Drug Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Dermatology OTC Drug Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Dermatology OTC Drug Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Dermatology OTC Drug Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Dermatology OTC Drug Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Dermatology OTC Drug Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Dermatology OTC Drug Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Dermatology OTC Drug Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Dermatology OTC Drug Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Dermatology OTC Drug Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Dermatology OTC Drug Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Dermatology OTC Drug Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Dermatology OTC Drug Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Dermatology OTC Drug Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Dermatology OTC Drug Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Dermatology OTC Drug Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Dermatology OTC Drug Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Dermatology OTC Drug Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Dermatology OTC Drug Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Dermatology OTC Drug Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Dermatology OTC Drug Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Dermatology OTC Drug Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Dermatology OTC Drug Market Size by Country (2022-2027) & (US$ Million)
Table 65. Bayer Company Details
Table 66. Bayer Business Overview
Table 67. Bayer Dermatology OTC Drug Product
Table 68. Bayer Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 69. Bayer Recent Development
Table 70. GSK Company Details
Table 71. GSK Business Overview
Table 72. GSK Dermatology OTC Drug Product
Table 73. GSK Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 74. GSK Recent Development
Table 75. Teva Company Details
Table 76. Teva Business Overview
Table 77. Teva Dermatology OTC Drug Product
Table 78. Teva Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 79. Teva Recent Development
Table 80. Johnson & Johnson Company Details
Table 81. Johnson & Johnson Business Overview
Table 82. Johnson & Johnson Dermatology OTC Drug Product
Table 83. Johnson & Johnson Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 84. Johnson & Johnson Recent Development
Table 85. Novartis Company Details
Table 86. Novartis Business Overview
Table 87. Novartis Dermatology OTC Drug Product
Table 88. Novartis Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 89. Novartis Recent Development
Table 90. Mylan Company Details
Table 91. Mylan Business Overview
Table 92. Mylan Dermatology OTC Drug Product
Table 93. Mylan Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 94. Mylan Recent Development
Table 95. Sun Pharmaceutical Company Details
Table 96. Sun Pharmaceutical Business Overview
Table 97. Sun Pharmaceutical Dermatology OTC Drug Product
Table 98. Sun Pharmaceutical Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 99. Sun Pharmaceutical Recent Development
Table 100. Aurobindo Company Details
Table 101. Aurobindo Business Overview
Table 102. Aurobindo Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 103. Aurobindo Recent Development
Table 104. Galderma Company Details
Table 105. Galderma Business Overview
Table 106. Galderma Dermatology OTC Drug Product
Table 107. Galderma Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 108. Galderma Recent Development
Table 109. CR SANJIU Company Details
Table 110. CR SANJIU Business Overview
Table 111. CR SANJIU Dermatology OTC Drug Product
Table 112. CR SANJIU Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 113. CR SANJIU Recent Development
Table 114. Dr. Reddy's Company Details
Table 115. Dr. Reddy's Business Overview
Table 116. Dr. Reddy's Dermatology OTC Drug Product
Table 117. Dr. Reddy's Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 118. Dr. Reddy's Recent Development
Table 119. Lupin Company Details
Table 120. Lupin Business Overview
Table 121. Lupin Dermatology OTC Drug Product
Table 122. Lupin Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 123. Lupin Recent Development
Table 124. Bausch Health Company Details
Table 125. Bausch Health Business Overview
Table 126. Bausch Health Dermatology OTC Drug Product
Table 127. Bausch Health Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 128. Bausch Health Recent Development
Table 129. Cipla Company Details
Table 130. Cipla Business Overview
Table 131. Cipla Dermatology OTC Drug Product
Table 132. Cipla Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 133. Cipla Recent Development
Table 134. Livzon Company Details
Table 135. Livzon Business Overview
Table 136. Livzon Dermatology OTC Drug Product
Table 137. Livzon Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 138. Livzon Recent Development
Table 139. Almirall Company Details
Table 140. Almirall Business Overview
Table 141. Almirall Dermatology OTC Drug Product
Table 142. Almirall Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 143. Almirall Recent Development
Table 144. Lingrui Company Details
Table 145. Lingrui Business Overview
Table 146. Lingrui Dermatology OTC Drug Product
Table 147. Lingrui Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 148. Lingrui Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dermatology OTC Drug Market Share by Type: 2020 VS 2027
Figure 2. Antifungals Medication Features
Figure 3. Skin Disinfection Medication Features
Figure 4. Skin Irritation Medication Features
Figure 5. Wounds and Herpes Simplex Medication Features
Figure 6. Anti-Psoriasis Medication Features
Figure 7. Other Features
Figure 8. Global Dermatology OTC Drug Market Share by Application: 2020 VS 2027
Figure 9. Hospital Case Studies
Figure 10. Drug Store Case Studies
Figure 11. Other Case Studies
Figure 12. Dermatology OTC Drug Report Years Considered
Figure 13. Global Dermatology OTC Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Dermatology OTC Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Dermatology OTC Drug Market Share by Regions: 2020 VS 2027
Figure 16. Global Dermatology OTC Drug Market Share by Regions (2022-2027)
Figure 17. Global Dermatology OTC Drug Market Share by Players in 2020
Figure 18. Global Top Dermatology OTC Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatology OTC Drug as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Dermatology OTC Drug Revenue in 2020
Figure 20. Global Dermatology OTC Drug Revenue Market Share by Type (2016-2021)
Figure 21. Global Dermatology OTC Drug Revenue Market Share by Type (2022-2027)
Figure 22. North America Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Dermatology OTC Drug Market Share by Type (2016-2027)
Figure 24. North America Dermatology OTC Drug Market Share by Application (2016-2027)
Figure 25. North America Dermatology OTC Drug Market Share by Country (2016-2027)
Figure 26. United States Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Dermatology OTC Drug Market Share by Type (2016-2027)
Figure 30. Europe Dermatology OTC Drug Market Share by Application (2016-2027)
Figure 31. Europe Dermatology OTC Drug Market Share by Country (2016-2027)
Figure 32. Germany Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Dermatology OTC Drug Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Dermatology OTC Drug Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Dermatology OTC Drug Market Share by Region (2016-2027)
Figure 42. China Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Dermatology OTC Drug Market Share by Type (2016-2027)
Figure 50. Latin America Dermatology OTC Drug Market Share by Application (2016-2027)
Figure 51. Latin America Dermatology OTC Drug Market Share by Country (2016-2027)
Figure 52. Mexico Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Dermatology OTC Drug Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Dermatology OTC Drug Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Dermatology OTC Drug Market Share by Country (2016-2027)
Figure 58. Turkey Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Bayer Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 62. GSK Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 63. Teva Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 64. Johnson & Johnson Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 66. Mylan Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 67. Sun Pharmaceutical Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 68. Aurobindo Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 69. Galderma Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 70. CR SANJIU Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 71. Dr. Reddy's Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 72. Lupin Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 73. Bausch Health Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 74. Cipla Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 75. Livzon Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 76. Almirall Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 77. Lingrui Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
  • 2021-2027 Global and Regional Angioplasty Balloons Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 21-Sep-2021        Price: US 3500 Onwards        Pages: 159
    The global Angioplasty Balloons market was valued at 1875.22 Million USD in 2020 and will grow with a CAGR of 2.88% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, E......
  • 2021-2027 Global and Regional Infrared Thermometer Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 21-Sep-2021        Price: US 3500 Onwards        Pages: 161
    The global Infrared Thermometer market was valued at 42.52 Million USD in 2020 and will grow with a CAGR of 2.44% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Eur......
  • United States Low Vision Aids Market Report & Forecast 2021-2027
    Published: 20-Sep-2021        Price: US 3400 Onwards        Pages: 94
    United States Low Vision Aids Market, By Type, 2016-2021, 2022-2027 ($ Millions) United States Low Vision Aids Market Segment Percentages, By Type, 2020 (%) - Optical Aids - Non-Optical Aids - Electronic Aids United States Low Vision Aids Market, By Application, 2016-2021, 2022-2027 ($ Millions) United States Low Vision Aids Market Segment Percentages, By Application, 2020 (%) - Hospital Pharmacies - Optical Stores - Retail P......
  • United States Low Temperature Plasma Sterilizer Market Report & Forecast 2021-2027
    Published: 20-Sep-2021        Price: US 3400 Onwards        Pages: 93
    United States Low Temperature Plasma Sterilizer Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Units) United States Low Temperature Plasma Sterilizer Market Segment Percentages, By Type, 2020 (%) - Below 100 L - 100-200 L - Above 200 L United States Low Temperature Plasma Sterilizer Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (Units) United States Low Temperature Plasma Sterilizer Market Segment Percentages, By Application,......
  • United States Loop-mediated Isothermal Amplification (LAMP) Kit Market Report & Forecast 2021-2027
    Published: 20-Sep-2021        Price: US 3400 Onwards        Pages: 94
    United States Loop-mediated Isothermal Amplification (LAMP) Kit Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units) United States Loop-mediated Isothermal Amplification (LAMP) Kit Market Segment Percentages, By Type, 2020 (%) - DNA - RNA United States Loop-mediated Isothermal Amplification (LAMP) Kit Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units) United States Loop-mediated Isothermal Amplification (LAMP) Kit Market Seg......
  • United States Livestock Animal Vaccines Market Report & Forecast 2021-2027
    Published: 20-Sep-2021        Price: US 3400 Onwards        Pages: 112
    United States Livestock Animal Vaccines Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Doses) United States Livestock Animal Vaccines Market Segment Percentages, By Type, 2020 (%) - Live Attenuated Vaccine - Inactivated Vaccine - Other Vaccines United States Livestock Animal Vaccines Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Doses) United States Livestock Animal Vaccines Market Segment Percentages, By Application, 20......
  • United States Liver Surgery and Neurosurgery Electrosurgical Units (ESUs) Market Report & Forecast 2021-2027
    Published: 20-Sep-2021        Price: US 3400 Onwards        Pages: 90
    United States Liver Surgery and Neurosurgery Electrosurgical Units (ESUs) Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Units) United States Liver Surgery and Neurosurgery Electrosurgical Units (ESUs) Market Segment Percentages, By Type, 2020 (%) - Monopole Electrosurgical Units - Bipolar Electrosurgical Units - Vessel Sealing Units United States Liver Surgery and Neurosurgery Electrosurgical Units (ESUs) Market, By Application, 2016-2021, 2022-......
  • United States Lighted Blanket Market Report & Forecast 2021-2027
    Published: 20-Sep-2021        Price: US 3400 Onwards        Pages: 91
    United States Lighted Blanket Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Units) United States Lighted Blanket Market Segment Percentages, By Type, 2020 (%) - Large Type - Small Type United States Lighted Blanket Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (Units) United States Lighted Blanket Market Segment Percentages, By Application, 2020 (%) - Hospitals & Clinics - Birthing Centers - Others ......
  • United States Ligament Stabilizer Market Report & Forecast 2021-2027
    Published: 20-Sep-2021        Price: US 3400 Onwards        Pages: 107
    United States Ligament Stabilizer Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units) United States Ligament Stabilizer Market Segment Percentages, By Type, 2020 (%) - Knee Braces & Supports - Foot and Ankle Braces & Supports - Shoulder Braces & Supports - Spinal Orthoses - Wrist & Hand Braces & Supports United States Ligament Stabilizer Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units) United States L......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs